Jia-Han Ding

1.3k citations
14 papers · 905 indexed · 2 hit papers · h-index 8

Impact in

Papers in

    • Cancer, Lipids, and Metabolism 3
    • Cancer Genomics and Diagnostics 2
    • Cancer Immunotherapy and Biomarkers 2
    • Cancer Cells and Metastasis 2

Jia-Han Ding

14 papers receiving 899 citations

Hit Papers

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy 2022 · 383 citations
3832022202620232024100200300

Peers

Jia-Han Ding
Comparison fields: 5 of 77
  • Cancer Research 402
  • Pulmonary and Respiratory Medicine 396
  • Oncology 277
  • Molecular Biology 484
  • Immunology 106
Replace Yuxi Zhu with:
Yuxi Zhu China
Zhefang Wang Germany
Yunhua Xu China
Katsuhiro Anami Japan
Monika Bauden Sweden
David James VanderWeele United States
W. H. Tian China
Cuiju Tang China
Jia-Han Ding relative to Yuxi Zhu China Yuxi Zhu's profile →
Citations per field
00.5×3.9×
Yuxi Zhu · 1×
Citations per year

Countries citing papers authored by Jia-Han Ding

Since Specialization
Citations

This map shows the geographic impact of Jia-Han Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia-Han Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia-Han Ding more than expected).

Fields of papers citing papers by Jia-Han Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia-Han Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia-Han Ding. The network helps show where Jia-Han Ding may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jia-Han Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jia-Han Ding Line = papers co-authored together Jia-Han Ding links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20252
2 202411
3 20231
4 20227
5
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Hit paper breakdown →
2022202
6
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
Hit paper breakdown →
2022383
7 202227
8 2020194
9 20195
10 201838
11 20105
12
[Establishment and characterization of human inflammatory breast carcinoma neoplasm transplantation in nude mice].
20012
13 198624
14
Bone marrow necrosis diagnosed during life: clinical and laboratory features of extensive involvement.
19814

About Jia-Han Ding

Jia-Han Ding is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Biochemistry and Orthopedics and Sports Medicine, having authored 14 papers that have together received 905 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (3 papers), Ferroptosis and cancer prognosis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers), Cancer Genomics and Diagnostics (2 papers), Synthesis and Characterization of Heterocyclic Compounds (1 paper) and Hemostasis and retained surgical items (1 paper). The work is most often cited by research in Cancer Research (402 citations), Pulmonary and Respiratory Medicine (396 citations), Oncology (277 citations), Molecular Biology (484 citations) and Immunology (106 citations). Jia-Han Ding has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yi‐Zhou Jiang, Yi Xiao, Ding Ma, Da‐Qiang Li, Fan Yang, Zhi‐Ming Shao, Yiping Wang, Jinxiu Shi, Wei Huang and Xi Jin. Their work appears in journals such as Cell Research, Journal of Clinical Pathology, Science Translational Medicine, Cell Metabolism and Molecular Therapy — Oncolytics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026